Nalaganje...
Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance
USP7 is a promising target for the development of cancer treatments because of its high expression and the critical functions of its substrates in carcinogenesis of several different carcinomas. Here, we demonstrated the effectiveness of targeting USP7 in advanced malignant cells showing high levels...
Shranjeno v:
| izdano v: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7697005/ https://ncbi.nlm.nih.gov/pubmed/33207738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21228629 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|